Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial

Fernanda Mosele, Élise Deluche, Amélie Lusque, +32

Nature Medicine

Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer

Fernanda Mosele, Bojana Stefanovska, Amélie Lusque, +19

Annals of Oncology

Breast OncologyMedicinePathologyCancer GenomicsBreast Cancer +5

Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

Thomas Bachelot, Thomas Filleron, Ivan Bièche, +29

Nature Medicine

Metastatic Breast CancerBreast OncologyMedicineImmunologyPathology +5

Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status

Dan Ou, Pierre Blanchard, Silvia Rosellini, +14

Oral Oncology

Adaptive RadiotherapyAdvanced HeadRadiomics SignatureRadiation TherapyMedicine +8

LBA1 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial

M.F. Mosele, Amélie Lusque, Véronique Dièras, +17

Annals of Oncology

Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy

Dan Ou, Julien Adam, Ingrid Garberis, +11

OncoImmunology

Neck CancerImmunologyPathologyImmunotherapyTreatment Resistance +18

Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy

Dan Ou, Julien Adam, Ingrid Garberis, +11

Radiotherapy and Oncology

Tumor-associated MacrophagesCancer ImmunosurveillanceHuman Papillomavirus VaccinesMedicineImmunology +10

Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?

Dan Ou, Antonin Lévy, Pierre Blanchard, +8

Oral Oncology

Advanced HeadConcurrent ChemoradiotherapyCervical CancerMedicinePathology +8

Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy

Dan Ou, Ingrid Garberis, Julien Adam, +11

Radiotherapy and Oncology

Cervical CancerPrognostic ValuePathologyTissue NecrosisNeck Pathology +6

Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis

Sylvie Rodrigues-Ferreira, Anne Nehlig, Clarisse Monchecourt, +12

Breast Cancer Research and Treatment

Combinatorial ExpressionOncologyEngineeringMedicineAtip3 Biomarkers +10